Rate My Professor Mohammed Razzaque

Mohammed Razzaque, MBBS, PhD, serves as Professor of Pathology in the Department of Medical Education at the University of Texas Rio Grande Valley School of Medicine. His academic journey began with an MBBS from Chittagong Medical College in Bangladesh, followed by a PhD in Pathology from Nagasaki University School of Medicine in Japan, where he also completed specialized training in renal pathology. Prior to his current role, Dr. Razzaque held prestigious positions including Professor of Pathology at Lake Erie College of Osteopathic Medicine in Erie, Pennsylvania, and at Saba University School of Medicine in the Dutch Caribbean. At Harvard School of Dental Medicine in Boston, Massachusetts, he progressed from Instructor to Assistant Professor in the Department of Oral Medicine & Diagnostic Sciences and served as Visiting Professor in the Department of Oral Health Policy & Epidemiology. Additionally, he worked as a consultant in renal pathology at Riyadh Military Hospital in Saudi Arabia.

Dr. Razzaque's research expertise lies in mineral ion metabolism, focusing on phosphate homeostasis and its implications for chronic kidney disease, vascular calcification, premature aging, and tumor-associated complications such as cachexia. He has authored more than 100 peer-reviewed manuscripts in leading journals like Cancer Cell, Proceedings of the National Academy of Sciences (PNAS), Journal of Cell Biology, FASEB Journal, Cell Reports, Journal of Biological Chemistry, Nature Reviews Endocrinology, and Trends in Molecular Medicine. Key publications include "The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis" (Nature Reviews Endocrinology, 2009), "Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation" (PNAS, 2010), "Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging" (FASEB Journal, 2010), "TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis" (Cancer Cell, 2015), and "Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia" (Developmental Cell, 2018). Funded by NIH R01 grants as Principal Investigator and Japanese Grants-in-Aid for Scientific Research, his work has established collaborative ties across the U.S., Europe, and Japan. He received Excellence in Tutoring Awards from Harvard Medical School's Academy Center for Teaching and Learning in 2011-12 and 2014-15. Dr. Razzaque has contributed to global medical education through the Human Resources for Health Program in Rwanda as a Harvard faculty representative, and by providing instruction and forging research partnerships at universities in Belgium and Kazakhstan. At UTRGV School of Medicine, he applies innovative, global teaching methods to equip students for healthcare challenges in the Rio Grande Valley and beyond, promoting continuous learning and community-focused leadership.